Edition:
United States

Allergan plc (AGN)

AGN on New York Consolidated

214.78USD
17 Jan 2017
Change (% chg)

$-1.36 (-0.63%)
Prev Close
$216.14
Open
$214.40
Day's High
$215.88
Day's Low
$211.43
Volume
3,866,058
Avg. Vol
4,692,587
52-wk High
$301.98
52-wk Low
$184.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 3.58 December 17 Jan 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 8 8 8 8
(2) OUTPERFORM 9 9 9 9
(3) HOLD 5 5 4 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.86 1.86 1.81 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 11 3,583.16 3,667.90 3,499.00 --
Quarter Ending Jun-17 11 3,816.17 3,903.00 3,757.00 --
Year Ending Dec-17 21 15,278.60 15,640.30 15,080.10 19,197.90
Earnings (per share)
Quarter Ending Mar-17 11 3.58 3.78 3.45 --
Quarter Ending Jun-17 11 3.94 4.14 3.75 --
Year Ending Dec-17 23 15.98 16.69 15.40 18.92
LT Growth Rate (%) 4 11.32 15.00 8.24 8.56

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-16 3,676.14 3,622.20 53.94 1.47
Quarter Ending Jun-16 4,106.25 3,684.80 421.45 10.26
Quarter Ending Mar-16 3,953.22 3,795.90 157.32 3.98
Quarter Ending Dec-15 4,192.40 4,197.50 5.10 0.12
Quarter Ending Sep-15 4,033.10 4,085.20 52.10 1.29
Earnings (per share)
Quarter Ending Sep-16 3.56 3.32 0.24 6.68
Quarter Ending Jun-16 3.34 3.35 0.01 0.19
Quarter Ending Mar-16 3.01 3.04 0.03 1.04
Quarter Ending Dec-15 3.34 3.41 0.07 2.06
Quarter Ending Sep-15 3.18 3.48 0.30 9.55

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 3,583.16 3,583.16 3,620.53 3,654.01 --
Quarter Ending Jun-17 3,816.17 3,816.17 3,845.62 3,865.88 --
Year Ending Dec-17 15,278.60 15,292.40 15,279.80 15,387.00 19,197.90
Earnings (per share)
Quarter Ending Mar-17 3.58 3.58 3.63 3.66 --
Quarter Ending Jun-17 3.94 3.94 3.99 3.99 --
Year Ending Dec-17 15.98 15.99 16.02 16.14 18.92

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 0 1 4
Quarter Ending Jun-17 0 0 1 4
Year Ending Dec-17 0 1 7 5
Earnings
Quarter Ending Mar-17 0 0 0 5
Quarter Ending Jun-17 0 0 1 5
Year Ending Dec-17 0 2 8 5